South San Francisco, CA March 3, 2015 Johnson & Johnson Press Release SAN FRANCISCO, March 3, 2015 /PRNewswire/ — Johnson & Johnson Innovation LLC today announced the opening of JLABS @South San Francisco (JLABS @SSF), a 30,000-square foot incubator…
Tag: Biopharmaceutica
California Healthcare Institute and Bay Area Bioscience Association Will Combine to Become the California Biomedical Innovation Alliance
South San Francisco, CA December 8, 2014 Press Release Bay Bio Sara Radcliffe Announced as CEO of Combined Entity PALO ALTO, Calif. and SAN DIEGO, Calif. – Dec. 8, 2014 – The California Healthcare Institute (CHI), a nonprofit, public…
FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer
South San Francisco, CA August 14, 2014 Submitted by Genentech Press Release SOUTH SAN FRANCISCO, CALIF. — 2014-08-14 Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced…
SSF Officials Conclude Successful Trip to BIO International Convention
South San Francisco, CA June 28, 2014 Submitted by City of South San Francisco South San Francisco city officials returned today from a successful business development trip to the Biotechnology Industry Organization (BIO) International Convention in San Diego. The…
New Janssen Labs Incubator Could Bring Up to 50 Companies to South SF
South San Francisco, CA May 14, 2014 Rebroadcast from Xcomony.com By Alex Lash Tiny biotech startups will have a new place to germinate in the San Francisco Bay Area. Healthcare giant Johnson & Johnson’s Janssen Labs division is opening a…
Genentech to Present New Data on 27 Different Medicines at ASCO
Genentech to Present New Data on 27 Different Medicines at ASCO Genentech to deliver new data on approved medicines, investigational targeted combinations and the emerging pipeline Data in more than 19 tumor types will be presented, including new results from…
OXiGENE, Inc. Announces $12 Million Public Offering
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2014 (GLOBE NEWSWIRE) — Press Release OXiGENE, Inc. (Nasdaq:OXGN) today announced that it has entered into definitive agreements with investors to purchase an aggregate of approximately $12 million of units, in a registered public…
Local South City Bioproduct Solazyme’s Wins Coveted Award
Solazyme’s Algenist Brand Wins Coveted 2014 Marie Claire Excellence in Beauty Award SOUTH SAN FRANCISCO, Calif.—January 21, 2014—Solazyme, Inc.(NASDAQ: SZYM), a renewable oil and bioproducts company, and maker of the skincare brand, Algenist®, today announced that the line has won…
Ferry not an option as AMGEN cleans up explosion
South San Francisco, CA January 8, 2014 Firefighters were called out to what was reported to be a structure fire today at 3:27pm at local biocompany AMGEN at 1120 Veterans in the East 101 area. Dispatch upped the response to…
Genentech deal amps up cancer immunotherapy push
Ron Leuty Reporter- San Francisco Business Times Jun 27, 2013, 5:58pm PDT Email | Twitter | Google+ | Twitter Genentech Inc. will seize on a new partner’s technology to develop a new generation of drugs that boost the immune system in its…